Know Labs, Inc. to Host Review of Third Quarter Fiscal Year 2023 Results on August 14, 2023
August 03 2023 - 9:00AM
Business Wire
Know Labs, Inc. (NYSE American: KNW), an emerging developer of
non-invasive medical diagnostic technology, today announced it will
host a webcast to review business updates and results for its third
quarter of the fiscal year 2023 ended on June 30, 2023, on August
14, 2023, beginning at 1:30 pm PT.
Media and investors may access the live audio webcast at
www.knowlabs.co/investors, beginning at 1:15 pm PT. Questions to
the Company’s management team can be submitted through the webcast
portal during the meeting. The webcast will also be available for
replay at the company’s website.
For more information on Know Labs and its progress in developing
non-invasive medical diagnostic technology, visit
www.knowlabs.co.
About Know Labs, Inc. Know Labs, Inc. is a public company
whose shares trade on the NYSE American Exchange under the stock
symbol “KNW.” The Company’s technology uses spectroscopy to direct
electromagnetic energy through a substance or material to capture a
unique molecular signature. The Company refers to its technology as
Bio-RFID™. The Bio-RFID technology can be integrated into a variety
of wearable, mobile or bench-top form factors. This patented and
patent-pending technology makes it possible to effectively identify
and monitor analytes that could only previously be performed by
invasive and/or expensive and time-consuming lab-based tests. The
first application of our Bio-RFID technology will be in a product
marketed as a non-invasive glucose monitor. The device will provide
the user with accessible and affordable real-time information on
blood glucose levels. This product will require U.S. Food and Drug
Administration clearance prior to its introduction to the
market.
Safe Harbor Statement This release contains statements
that constitute forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995 and Section
27A of the Securities Act of 1933, as amended, and Section 21E of
the Securities Exchange Act of 1934, as amended. These statements
appear in a number of places in this release and include all
statements that are not statements of historical fact regarding the
intent, belief or current expectations of Know Labs, Inc., its
directors or its officers with respect to, among other things: (i)
financing plans; (ii) trends affecting its financial condition or
results of operations; (iii) growth strategy and operating
strategy; and (iv) performance of products. You can identify these
statements by the use of the words “may,” “will,” “could,”
“should,” “would,” “plans,” “expects,” “anticipates,” “continue,”
“estimate,” “project,” “intend,” “likely,” “forecast,” “probable,”
“potential,” and similar expressions and variations thereof are
intended to identify forward-looking statements. Investors are
cautioned that any such forward-looking statements are not
guarantees of future performance and involve risks and
uncertainties, many of which are beyond Know Labs, Inc.’s ability
to control, and actual results may differ materially from those
projected in the forward-looking statements as a result of various
factors. These risks and uncertainties also include such additional
risk factors as are discussed in the Company’s filings with the
U.S. Securities and Exchange Commission, including its Annual
Report on Form 10-K for the fiscal year ended September 30, 2022,
Forms 10-Q and 8-K, and in other filings we make with the
Securities and Exchange Commission from time to time. These
documents are available on the SEC Filings section of the Investor
Relations section of our website at www.knowlabs.co. The Company
cautions readers not to place undue reliance upon any such
forward-looking statements, which speak only as of the date made.
The Company undertakes no obligation to update any forward-looking
statement to reflect events or circumstances after the date on
which such statement is made.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230803732918/en/
For Know Labs Media Inquiries Contact: Matter Health
Laura Bastardi Knowlabs@matternow.com Ph. (603) 494-6667 Know
Labs, Inc. Contact: Jordyn Hujar jordyn@knowlabs.co Ph. (206)
629-6414
Know Labs (AMEX:KNW)
Historical Stock Chart
From Jun 2024 to Jul 2024
Know Labs (AMEX:KNW)
Historical Stock Chart
From Jul 2023 to Jul 2024